Tetrahydrocannabivarin (THCV) is one of the most medically important of the known cannabinoids. It is thought to act as an antagonist of the cannabinoid receptors at low doses, but surprisingly, it may act as an agonist at high doses, giving effects similar to THC. Since its discovery in 1973, THCV has gradually grown in importance within medical circles.
Tetrahydrocannabivarin (THCV) is one of the better-studied and most medically important of the known cannabinoids. It is thought to act as an antagonist of the cannabinoid receptors at low doses, but surprisingly, it may act as an agonist at high doses, giving effects similar to THC.
Since its discovery in 1973, THCV has gradually grown in importance within medical circles, and over the last ten years or so, research into its pharmacological properties has started to intensify. Like CBD, it is thought to have important roles to play in the regulation of the immune system, particularly with regards to inflammation and inflammatory pain.